Supply Chain

Forty percent of all clinicians and other stakeholders say their hospital has cancelled a surgical case due to missing supplies, and more critically, 27 percent knew of a patient being harmed due to supply chain problems.1

The FDA issued two policies April 12 to establish approaches for the design and validation of next-generation sequencing tests.

 Many U.S. drug suppliers saw their stock prices rise April 16 following the news Amazon dropped its plan to sell and distribute pharmaceutical products to hospitals, reports Reuters.

Amazon Business, the e-commerce giant's separate business-to-business marketplace, shelved its push to become a major pharmaceutical supplier to large U.S. hospitals and outpatient clinics, reports CNBC.

London-based rare disease drugmaker Shire divested its oncology business to the French drug company Servier for $2.4 billion, reports Reuters.

FDA Commissioner Gottleib recently stated at the February FDA Drug Supply Chain Security Act (DSCSA) public meeting that "Making sure that every link in the U.S. Drug Supply must be secure." and that, "Full implementation of the Drug Supply Chain…

After the Trump administration outlined a number of actions the federal government should take to address rising drug prices, two prescribing physicians argue these proposals may not only fail to lower drug prices, but also significantly limit Medicare patients' access to…

GlaxoSmithKline divested its portfolio of rare disease gene therapies to Orchard Therapeutics through a strategic agreement, the company announced April 12.

Here are the three latest drugs or medical devices approved by the FDA since March 23.

CVS Health tapped Marc-David Munk, MD, to serve as the CMO of MinuteClinic, the drugstore chain's retail medical clinic division and as the Associate CMO of CVS Health.